Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
50.37
+1.00 (2.03%)
At close: Aug 21, 2026, 4:00 PM EDT
50.82
+0.45 (0.89%)
After-hours: Aug 21, 2026, 7:59 PM EDT
Boston Scientific Stock Forecast
Stock Price Forecast
According to 31 analysts polled by S&P Global, Boston Scientific stock has a consensus rating of "Buy" and an average price target of $62.69. The average 1-year stock price forecast is 24.46% higher than the current stock price, while the lowest is $44 (-12.65%) and the highest is $94 (+86.62%).
Price Target: $62.69 (+24.46%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Boston Scientific stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 24 | 22 | 21 | 20 | 18 | 18 |
| Buy | 10 | 9 | 7 | 7 | 8 | 8 |
| Hold | 0 | 2 | 4 | 4 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 34 | 33 | 32 | 31 | 31 | 31 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Reiterates $60 | Buy | Reiterates | $60 | +19.12% | Aug 21, 2026 |
| Citi | Citi | Buy Maintains $61 | Buy | Maintains | $61 | +21.10% | Aug 13, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $20 → $54 | Buy | Maintains | $20 → $54 | +7.21% | Aug 11, 2026 |
| Argus Research | Argus Research | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Jul 31, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $70 → $60 | Buy | Maintains | $70 → $60 | +19.12% | Jul 31, 2026 |
Financial Forecast
Revenue This Year
21.37B
from 20.07B
Increased by 6.44%
Revenue Next Year
22.34B
from 21.37B
Increased by 4.54%
EPS This Year
3.30
from 3.06
Increased by 7.96%
EPS Next Year
3.44
from 3.30
Increased by 4.08%
EPS and Forward PE are based on non-GAAP adjusted numbers.